ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Methyl isobutyrate → 2-[6-[(4-tert-Butylphenyl)sulfonyl]-2-(trifluoromethyl)-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-8-yl]-2-methylpropanoic acid methyl ester

HRID 1691445
印刷

反応式

HRID 1691445 の反応式
[C:1]([O:6][CH3:7])(=[O:5])[CH:2]([CH3:4])[CH3:3].[Li+].C[Si]([N-][Si](C)(C)C)(C)C.Br[C:19]1[CH:20]=[CH:21][C:22]2[NH:28][C:27]3[N:29]=[C:30]([C:33]([F:36])([F:35])[F:34])[CH:31]=[CH:32][C:26]=3[CH2:25][N:24]([S:37]([C:40]3[CH:45]=[CH:44][C:43]([C:46]([CH3:49])([CH3:48])[CH3:47])=[CH:42][CH:41]=3)(=[O:39])=[O:38])[C:23]=2[CH:50]=1.F[B-](F)(F)F.C([PH+](C(C)(C)C)C(C)(C)C)(C)(C)C>C1(C)C=CC=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.C1C=CC(/C=C/C(/C=C/C2C=CC=CC=2)=O)=CC=1.[Pd]>[CH3:7][O:6][C:1](=[O:5])[C:2]([C:19]1[CH:20]=[CH:21][C:22]2[NH:28][C:27]3[N:29]=[C:30]([C:33]([F:35])([F:36])[F:34])[CH:31]=[CH:32][C:26]=3[CH2:25][N:24]([S:37]([C:40]3[CH:41]=[CH:42][C:43]([C:46]([CH3:48])([CH3:47])[CH3:49])=[CH:44][CH:45]=3)(=[O:39])=[O:38])[C:23]=2[CH:50]=1)([CH3:4])[CH3:3]
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 11039Methyl isobutyrateHCID 2733832Lithium hexamethyldisilazaneHCID 2734635Tri-tert-butylphosphine tetrafluoroborateHCID 596186368-bromo-6-[(4-tert-butylphenyl)sulfonyl]-2-(trifluoromethyl)-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepine

生成物 1

HCID 59618702
2-[6-[(4-tert-Butylphenyl)sulfonyl]-2-(trifluoromethyl)-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-8-yl]-2-methylpropanoic acid methyl ester

試薬・触媒・溶媒 2

HCID 6505921(1E,4E)-1,5-diphenylpenta-1,4-dien-3-one; palladium触媒HCID 1140Toluene溶媒

実験手順

To methyl isobutyrate (128 mg, 1.25 mmol) in toluene (5 mL) was added 1.46 mL of LiHMDS (1.0 M in PhMe, 1.46 mmol) at 0° C. After stirring at rt for 10-15 min, the mixture was transferred via cannula to a mixture of intermediate 53 (225 mg, 0.416 mmol), Pd(dba)2 (24 mg, 0.042 mmol), and tri-t-butylphosphonium tetrafluoroborate (12 mg, 0.042 mmol). After stirring at rt for 48 hrs, the reaction was quenched with aqueous NH4Cl (20 mL) and the product was extracted with EtOAc (50 mL). The extracts were washed with water (30 mL) and brine (30 mL), dried over MgSO4, filtered, and concentrated in vacuo. The residue was purified on silica gel column eluting with 5-30% EtOAc in hexanes to afford the title compound. LCMS: m/e 562.2 (M+H)+.

後処理

  1. stirringAfter stirring at rt for 48 hrs
  2. customthe reaction was quenched with aqueous NH4Cl (20 mL)
  3. extractionthe product was extracted with EtOAc (50 mL)
  4. washThe extracts were washed with water (30 mL) and brine (30 mL)
  5. dry with materialdried over MgSO4
  6. filtrationfiltered
  7. concentrationconcentrated in vacuo
  8. customThe residue was purified on silica gel column
  9. washeluting with 5-30% EtOAc in hexanes

出典と根拠

ORDレコード
ord-8f21da8eedde4cd0b0722064304045bf
出典データセット
uspto-grants-2012_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08153626B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート